Pharmaceuticals: Current Affairs, GK & News - 2020-2021

Chinese scientists discover XMU-MP-1 molecule to repair organs

Published: August 20, 2016

Chinese scientists have discovered a small molecule (new drug) named XMU-MP-1 that can regenerate tissue. It has potential to eliminate transplants of some organs. It was discovered by team of researchers from Xiamen University and  Peking University of China. The findings were published in Science Translational Medicine. Key Facts The drug, XMU-MP-1 can promote repair ..

Month: 

Topics: 

Cabinet Committee on Economic Affairs (CCEA) approved Rs.1750 crore for strengthening the drug regulatory system

Published: August 13, 2015

The Cabinet Committee on Economic Affairs (CCEA) has approved Rs.1750 crore for strengthening the drug regulatory system both at the Central and the State. The sanctioned amount will be spent for strengthening and up-gradation of the drug regulatory system over a period of three years. The total amount of Rs 1750 crore will be divided ..

Month: 

Topics: 

DRDO developed poly-herbal medicine to treat Leucoderma

Published: August 8, 2015

Defence Research and Development Organisation (DRDO) has developed a poly-herbal medicine by the trade name of Lukoskin for the treatment of Leucoderma. It was announced by Union Defence Minister Manohar Parrikar in a written reply to Rajya Sabha. The medicine was developed by Haldwani (Uttarakhand) based scientists of Defence Bio-Energy Research (DIBER), which is a ..

Month: 

Topics: 

US FDA hikes fee for generic drug approvals

Published: August 5, 2015

United state Food and Drugs Administration (USFDA) has hiked its fees by 30 percent for new generic drug applications. Earlier the fee for Abbreviated New Drug Applications (ANDAs) was 58,730 dollars and now has risen by 30 per cent to 76,030 US dollars. This fee is applicable from 1 October 2015. This move will hit Indian ..

Month: 

Topics: 

USFDA approves first anti-epilepsy pill manufactured with 3D printer

Published: August 5, 2015

Aprecia’s Spritam becomes first anti-epilepsy pill manufactured with 3D printer to get the US Food and Drug Administration (USFDA) approval. The specified porous structure of the pill ‘Spritam’ was developed by using ZipDose 3D printing technology by Aprecia Pharmaceuticals. Designing detail structure of the Spritam pill made it possible for Aprecia to develop a pill that ..

Month: 

Topics: 

Advertisement